Concerns have been raised about high rates of mortality and major bleeding with the Impella intravascular microaxial left ventricular assist device (LVAD) among patients undergoing PCI for acute MI complicated by cardiogenic shock. An observational study published in JAMA involving 3360 patients receiving mechanical circulatory support has found that inhospital mortality rates were 11 percentage ...
Ischaemic heart disease
Impella mortality data raise concerns over use of device in cardiogenic shock
By Sharon Smith
27 Feb 2020